Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gerilimzumab in Rheumatoid Arthritis
NCT02795299Phase 2Withdrawn
- Sponsor
- Bird Rock Bio
- Start
- Jan 2018
- Primary completion
- May 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of gerilimzumab in rheumatoid arthritis (RA), sponsored by Bird Rock Bio. Planned start Jan 2018; status: withdrawn.
02
Drugs
gerilimzumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02795299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02795299.